Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabrizio Fanizzi
Observed name:
F Fanizzi
Institutions:
Vita-Salute San Raffaele University,
IRCCS Ospedale San Raffaele
Observed institutions:
Vita-Salute San Raffaele University,
IRCCS Ospedale San Raffaele
ORCID:
0009-0005-1198-6121
Observed ORCID:
0009-0005-1198-6121
OpenAlex ID:
A5106676371
The Role of Fecal Microbiota Transplantation in IBD
2024
·
Fabrizio Fanizzi
, Ferdinando D’Amico
, et al.
·
Microorganisms
·
52
PDF
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies
2025
·
Giuseppe Dell’Anna
, Fabrizio Fanizzi
, et al.
·
Nutrients
·
33
PDF
Targeting the unmet needs in IBD: Emerging therapies beyond biologics and small molecules
2025
·
Fabrizio Fanizzi
, Laurent Peyrin-Biroulet
, et al.
·
Current Opinion in Pharmacology
·
24
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches
2025
·
Lucia Centanni
, Clelia Cicerone
, et al.
·
Pharmaceuticals
·
23
PDF
Raising the bar in ulcerative colitis management
2024
·
Fabrizio Fanizzi
, Mariangela Allocca
, et al.
·
Therapeutic Advances in Gastroenterology
·
19
Treatment targets in IBD: is it time for new strategies?
2025
·
Fabrizio Fanizzi
, Ferdinando D'Amico
, et al.
·
Best Practice & Research Clinical Gastroenterology
·
15
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes
2025
·
Sara Massironi
, Lorenzo Gervaso
, et al.
·
Cancers
·
8
PDF
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-Line Therapy in Anti-Tumor Necrosis Factor-Experienced Patients With Ulcerative Colitis
2026
·
Giuseppe Privitera
, Cristina Bezzio
, et al.
·
Clinical Gastroenterology and Hepatology
·
7
Revolutionizing UC monitoring: The emerging role of intestinal ultrasound
2025
·
Fabrizio Fanizzi
, Alessandra Zilli
, et al.
·
Current Opinion in Pharmacology
·
3
Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis
2024
·
Francesca Bernardi
, Fabrizio Fanizzi
, et al.
·
Microorganisms
·
3
PDF
Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study
2026
·
Ferdinando D’Amico
, Fabrizio Fanizzi
, et al.
·
Journal of Crohn s and Colitis
·
2
Positioning Guselkumab in The Treatment Algorithm for Ulcerative Colitis
2026
·
Ferdinando D'Amico
, Fabrizio Fanizzi
, et al.
·
Journal of Inflammation Research
·
1
PDF
Cutaneous autoimmune blistering disease during mirikizumab therapy in a patient with ulcerative colitis: a new potential trigger?
2026
·
Lucia Centanni
, Fabrizio Fanizzi
, et al.
·
Journal of Crohn s and Colitis
·
1
Emerging role of intestinal ultrasound in detecting postoperative recurrence in Crohn’s disease
2026
·
Fabrizio Fanizzi
, Ferdinando D’Amico
, et al.
·
Gastroenterology report
·
1
International practice patterns in the management of pouchitis: results from a global survey
2026
·
Fabrizio Fanizzi
, Ferdinando D’Amico
, et al.
·
Crohn s & Colitis 360
PDF
Advanced Therapies for the Management of Immune Checkpoint Inhibitor-Induced Colitis
2026
·
Cosimo Simone Matichecchia
, Fabrizio Fanizzi
, et al.
·
Cancers
Raising the Bar in Crohn’s Disease: Is Transmural Healing Achievable?
2026
·
Fabrizio Fanizzi
, Alessandra Zilli
, et al.
·
Diagnostics
Intestinal Ultrasound-Guided Precision Medicine in Inflammatory Bowel Diseases: A Narrative Review
2026
·
Cicerone Clelia
, Fabrizio Fanizzi
, et al.
·
Journal of Personalized Medicine
PDF
Tu1583 WASH-OUT PERIOD IN THE TRANSITION FROM BIOLOGICS TO SMALL MOLECULES HAS NO IMPACT ON SAFETY IN IBD: A RETROSPECTIVE COHORT STUDY
2026
·
Fabrizio Fanizzi
, Ferdinando D’Amico
, et al.
·
Gastrointestinal Endoscopy
Tu1583 WASH-OUT PERIOD IN THE TRANSITION FROM BIOLOGICS TO SMALL MOLECULES HAS NO IMPACT ON SAFETY IN IBD: A RETROSPECTIVE COHORT STUDY
2026
·
Fabrizio Fanizzi
, Ferdinando D’Amico
, et al.
·
Gastroenterology
Mo1581 EFFECTIVENESS AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A REAL-LIFE MULTICENTER STUDY
2026
·
Ferdinando D’Amico
, Fabrizio Fanizzi
, et al.
·
Gastrointestinal Endoscopy
Mo1581 EFFECTIVENESS AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A REAL-LIFE MULTICENTER STUDY
2026
·
Ferdinando D’Amico
, Fabrizio Fanizzi
, et al.
·
Gastroenterology
Inflammatory bowel disease and primary sclerosing cholangitis: immunological links and clinical outlook
2026
·
Sara Massironi
, Fabrizio Fanizzi
, et al.
·
Expert Review of Clinical Immunology
Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
2026
·
Cristina Lanzotti
, Fabrizio Fanizzi
, et al.
·
Expert Opinion on Emerging Drugs
P0573 Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: a real-life multicenter study
2026
·
F D’Amico
, F Fanizzi
, et al.
·
Journal of Crohn s and Colitis
Show more works
View as search
Works count:
28
Citation count:
192
H-index:
7
I10-index:
6
Year
Topic
Type